These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38736621)

  • 1. The transcription factor sex-determining region Y-box 2 (SOX2) in bladder cancer.
    Griffin RL; Shuman L; Yamashita H; Wu Q; Chen G; Brown RM; Vander Griend D; DeGraff DJ; Warrick JI
    Am J Clin Exp Urol; 2024; 12(2):88-99. PubMed ID: 38736621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
    Belgorosky D; Girouard J; Langle YV; Hamelin-Morrissete J; Marino L; Agüero EI; Malagrino H; Reyes-Moreno C; Eiján AM
    J Mol Med (Berl); 2020 Nov; 98(11):1615-1627. PubMed ID: 32955679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
    Ruan J; Wei B; Xu Z; Yang S; Zhou Y; Yu M; Liang J; Jin K; Huang X; Lu P; Cheng H
    Med Oncol; 2013 Mar; 30(1):445. PubMed ID: 23307254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Fukuta F; Masumori N; Sato N; Tsukamoto T
    Mod Pathol; 2013 Jan; 26(1):117-24. PubMed ID: 22899292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer.
    Warrick JI; Raman JD; Kaag M; Bruggeman T; Cates J; Clark P; DeGraff DJ
    Urol Oncol; 2016 Jun; 34(6):258.e1-6. PubMed ID: 26976725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of Sex-Determining Region Y-Box 2 and CD8+ Tumor-Infiltrating Lymphocytes in Limited-Stage Small-Cell Lung Cancer.
    Lee J; Jung YY; Lee JH; Hong M; Hwang HW; Hong SA; Hong SH
    Oncology; 2021; 99(8):528-538. PubMed ID: 34107469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma.
    Warrick JI; Knowles MA; Hurst CD; Shuman L; Raman JD; Walter V; Putt J; Dyrskjøt L; Groeneveld C; Castro MAA; Robertson AG; DeGraff DJ
    Sci Rep; 2022 Oct; 12(1):16538. PubMed ID: 36192513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype.
    Yang F; Zhou Q; Meng L; Xing N
    Medicine (Baltimore); 2019 Jul; 98(27):e16009. PubMed ID: 31277094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
    Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
    PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of SOX2 function and regulation on therapy resistance in bladder cancer.
    Chen G; Chen Y; Xu R; Zhang G; Zou X; Wu G
    Front Oncol; 2022; 12():1020675. PubMed ID: 36465380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
    Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A
    Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of sex-determining region Y-box 2 in cell pluripotency and tumor-related signaling pathways.
    Wang J; Zeng H; Li H; Zhang J; Wang S
    Mol Clin Oncol; 2015 Nov; 3(6):1203-1207. PubMed ID: 26807221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of microRNA 638 and sex-determining region Y-box 2 in hepatocellular carcinoma: Association between clinicopathological features and prognosis.
    Ye W; Li J; Fang G; Cai X; Zhang Y; Zhou C; Chen L; Yang W
    Oncol Lett; 2018 May; 15(5):7255-7264. PubMed ID: 29731884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.
    Ottley EC; Pell R; Brazier B; Hollidge J; Kartsonaki C; Browning L; O'Neill E; Kiltie AE
    J Pathol Clin Res; 2020 Oct; 6(4):238-251. PubMed ID: 32374509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer.
    Zhu J; Livasy C; Donahue EE; Symanowski JT; Grigg CM; Brown LC; Matulay JT; Kearns JT; Raghavan D; Burgess EF; Clark PE
    Transl Androl Urol; 2023 Feb; 12(2):228-240. PubMed ID: 36915891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder.
    Plage H; Samtleben H; Hofbauer S; Kornienko K; Weinberger S; Bruch PG; Elezkurtaj S; Roßner F; Schallenberg S; Kluth M; Lennartz M; Blessin NC; Marx AH; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Klatte T; Schlomm T; Horst D; Zecha H
    Hum Pathol; 2022 Dec; 130():10-17. PubMed ID: 36152841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity.
    Züllig L; Roessle M; Weber C; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H; Huber GF
    Eur J Cancer; 2013 May; 49(8):1915-22. PubMed ID: 23414798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.